Elisabeth Heath M.D.__肾癌_美国专家_我的专家_全球会诊

您现在的位置是：首页>权威专家> 肾癌

Elisabeth Heath M.D.

所在科室：外科

就职医院：Karmanos cancer center

医生擅长：

在线咨询医学顾问电话热线：400-666-7998

医生介绍

· Gender

· Female

· Multidisciplinary Team(s)

· Genitourinary Oncology

· Department/Research Program(s)

· Department of Oncology

· Cancer Type(s)

· Adrenal Cancer
Bladder cancer
Kidney Cancer
Penile Cancer
Prostate Cancer
Testicular Cancer
Ureter Cancer
Urethra Cancer

· Contact Info

· Email:
heathe@karmanos.org

来自 <http://www.karmanos.org/physicians/Elisabeth-Heath?Disease=229&PageIndex=0&SortDirection=1>

· Education

· Fellowship
Medical oncology Fellowship: Johns Hopkins School of Medicine and Hospital, Baltimore, MD
Medical School
Jefferson Medical College
Residency
Georgetown University School of Medicine and Hospital, Washington, DC
Graduate Training
Jefferson Medical College

· Professional Memberships/Associations

· American Society of Clinical Oncology
American Association for Cancer Research
Southwest oncology Group

· Board Certifications

· Internal Medicine
American Board of Internal Medicine

· Clinical Interests

· Medical Oncology

· Research Interests

· Multidisciplinary care of patients with prostate, kidney, bladder, testicular cancer and Phase I clinical trials.

· Awards

· 2011 Blue Cross Blue Shield of Michigan Foundation, McDevitt Excellence in Research Award
2011 Wayne State University, Physician Golden Heart Faculty Award
Detroit's Top Docs, Hour Magazine
2010 NCI Cancer Clinical Investigator Team Leadership Award
2010 The Spirit of Detroit Award

· Publications

· First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother Pharmacol. 2011 Oct 22. PMID: 22020315 Authors: Chung V, Heath EI, Schelman WR, Johnson BM, Kirby LC, Lynch KM, Botbyl JD, Lampkin TA, Holen KD.
A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. Invest New Drugs. 2011 Aug 3. PMID: 21799472 Authors: Heath EI, Forman K, Malburg L, Gainer S, Suttle AB, Adams L, Ball H, Lorusso P.
Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction. Anticancer Drugs. 2011 Sep;22(8):794-800. PMID: 21799472 Authors: Gupta S, Parsa V, Heilbrun LK, Smith DW, Dickow B, Heath E, Vaishampayan
Inhibition of HDAC1 by Maspin Abrogates Epigenetic Silencing of Glutathione S-Transferase Pi (GSTp) in Prostate Carcinoma Cells. Mol Cancer Res. 2011 May 26. PMID: 21622623 Authors: Li X, Kaplun A, Lonardo F, Heath EI, Sakr FH, Irish J, Sakr WA, Sheng S.
Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol. 2011 Jan 1;2(1):18-24. PMID: 21503272 Authors: Zafar SF, Heilbrun LK, Vishnu P, Jasti P, Venkatramanamoorthy R, Ding L, Lorusso PM, Heath EI.

相关报道资讯

视频科普